The opportunity for companies within this sector is massive we are now talking about an industry that is currently worth over US$ 100 billion with the potential in the next 6.5 years to be worth over US$ 200 billion.
Browsing Tag
GTBP
37 posts
Are These 3 Biotech Stocks On Your Watch List in October?
Small-Cap Biotechnology Stocks Are Starting To Outperform Blue-Chips Biotechnology stocks are currently…
3 Top Biotech Stocks To Monitor In October
Over the past three months, the Nasdaq Biotechnology index has tumbled around 9.5% and…
Biotechnology Stocks Gaining Ground In October; What To Watch
It doesn’t matter what the broader markets do sometimes. Small-cap biotech stocks…
Are Small-Cap Biotech Stocks Worth Watching? 2 Gaining Ground This Month
Are Small-Cap Biotech Stocks Part Of Your Strategy? Some say yes, some…
Top Healthcare Stocks To Watch On Tuesday Morning
Biotechnology stocks are a subset of a much broader sector, healthcare. Where…
Top Biotechnology Stocks To Watch After Latest News
Biotechnology stocks have had a wild year so far. The latest trend…
GT Biopharma (GTBP) Announces HIV TriKE™ Data Demonstrating NK Cell Killing of Patient HIV Infected Cells
TAMPA, Florida , Oct. 3, 2019 /CNW/ — GT Biopharma, Inc. (GTBP)…
GT Biopharma (GTBP) Announces HIV Trike™ Data to be Published
LOS ANGELES, Sept. 26, 2019 /PRNewswire/ — GT Biopharma, Inc. (GTBP) (GTBP.PA) an immuno-oncology…
GT Biopharma (GTBP) Announces the Sale of Its Fixed Dose Combination Tablet (GTB-004) for Myasthenia Gravis (Chronic Autoimmune Disease) to DAS Therapeutics
TAMPA, Florida, Sept. 24, 2019 /PRNewswire/ — GT Biopharma, Inc. (GTBP) (GTBP.PA) an immuno-oncology…